Lalmohan Maji

Chingleput, TN 603203, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Privileged nitrogen heterocycles in anticancer drug discovery: recent advances on imidazole, indole, and pyrimidine scaffolds.

Privileged nitrogen heterocycles in anticancer drug discovery: recent advances on imidazole, indole, and pyrimidine scaffolds.

Journal: RSC advances

Published: March 29, 2026

Exploration of a Novel Imidazo[4,5-b]pyridine-dihydropyrimidinone hybrids as aurora kinase a inhibitors: integrated pharmacophore modelling, docking and simulation approaches.

Exploration of a Novel Imidazo[4,5-b]pyridine-dihydropyrimidinone hybrids as aurora kinase a inhibitors: integrated pharmacophore modelling, docking and simulation approaches.

Journal: Molecular diversity

Published: February 13, 2026

Exploring tetrazole chemistry: synthetic techniques, structure-activity relationship, and pharmacological insights in antimicrobial and anticancer therapy.

Exploring tetrazole chemistry: synthetic techniques, structure-activity relationship, and pharmacological insights in antimicrobial and anticancer therapy.

Journal: Frontiers in chemistry

Published: September 06, 2025

Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure-activity relationship.

Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure-activity relationship.

Journal: Molecular diversity

Published: November 12, 2024

Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance.

Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance.

Journal: European journal of medicinal chemistry

Published: September 20, 2024

Recent advancements in mechanistic research, therapeutic potential, and structure-activity relationships of aurora kinase inhibitors in cancer therapies.

Recent advancements in mechanistic research, therapeutic potential, and structure-activity relationships of aurora kinase inhibitors in cancer therapies.

Journal: Bioorganic chemistry

Published: September 20, 2024

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.

Journal: European journal of medicinal chemistry

Published: April 09, 2024

Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.

Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.

Journal: Molecular diversity

Published: October 26, 2023

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC).

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC).

Journal: Journal of biomolecular structure & dynamics

Published: August 29, 2023

An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review.

An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review.

Journal: Journal of biomolecular structure & dynamics

Published: May 09, 2023

Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase.

Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase.

Journal: Journal of biomolecular structure & dynamics

Published: May 05, 2023

Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.

Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.

Journal: Chemistry & biodiversity

Published: April 09, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026